Adicet Bio Inc (NASDAQ: ACET) is -41.27% lower on its value in year-to-date trading and has touched a low of $0.89 and a high of $3.77 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ACET stock was last observed hovering at around $0.96 in the last trading session, with the day’s gains setting it 0.15%.
Currently trading at $1.11, the stock is -0.85% and -15.06% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.3 million and changing 15.59% at the moment leaves the stock -31.18% off its SMA200. ACET registered 0.00% loss for a year compared to 6-month loss of -25.00%. The firm has a 50-day simple moving average (SMA 50) of $1.3068 and a 200-day simple moving average (SMA200) of $1.61295.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -21.28% gain in the last 1 month and extending the period to 3 months gives it a -25.00%, and is 14.78% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 9.04% over the week and 9.05% over the month.
Adicet Bio Inc (ACET) has around 143 employees, a market worth around $105.73M and $0.00M in sales. Distance from 52-week low is 25.28% and -70.56% from its 52-week high. The company has generated returns on investments over the last 12 months (-52.06%).
The EPS is expected to grow by 53.78% this year
107.0 institutions hold shares in Adicet Bio Inc (ACET), with institutional investors hold 77.67% of the company’s shares. The shares outstanding are 82.40M, and float is at 66.22M with Short Float at 5.51%. Institutions hold 76.44% of the Float.
The top institutional shareholder in the company is ORBIMED ADVISORS LLC with over 11.45 million shares valued at $13.85 million. The investor’s holdings represent 14.4769 of the ACET Shares outstanding. As of 2024-06-30, the second largest holder is TANG CAPITAL MANAGEMENT LLC with 8.22 million shares valued at $9.94 million to account for 10.3918 of the shares outstanding. The other top investors are RA CAPITAL MANAGEMENT, L.P. which holds 7.54 million shares representing 9.5369 and valued at over $9.12 million, while GOLDMAN SACHS GROUP INC holds 5.4171 of the shares totaling 4.28 million with a market value of $5.18 million.
Adicet Bio Inc (ACET) Insider Activity
The most recent transaction is an insider sale by Kauffman Michael, the company’s Director. SEC filings show that Kauffman Michael sold 5,900 shares of the company’s common stock on Jun 05 ’24 at a price of $1.43 per share for a total of $8437.0. Following the sale, the insider now owns 5900.0 shares.
Adicet Bio Inc disclosed in a document filed with the SEC on Jan 25 ’24 that ORBIMED ADVISORS LLC (Director) bought a total of 3,125,000 shares of the company’s common stock. The trade occurred on Jan 25 ’24 and was made at $2.40 per share for $7.5 million. Following the transaction, the insider now directly holds 7.53 million shares of the ACET stock.
Still, SEC filings show that on Jan 25 ’24, GORDON CARL L (Director) acquired 3,125,000 shares at an average price of $2.40 for $7.5 million. The insider now directly holds 7,526,359 shares of Adicet Bio Inc (ACET).
